Recruiting

DiosminStudy of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

Sponsor:

Primus Pharmaceuticals

Code:

NCT06256575

Conditions

Scleroderma, Systemic

Digital Ulcer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Diosmin

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Primus Pharmaceuticals on 2025-12-04.